Rapp Karen Marie sold $135K of PLXS
Rapp Karen Marie sold 500 shares of PLEXUS CORP (PLXS) at $270.00 ($0.14M total) on 2026-06-01 under a Rule 10b5-1 trading plan.
Insider selling disclosed via Form 4; likely low fundamental signal given pre-arranged 10b5-1, but can affect near-term sentiment/positioning.
PLEXUS director Karen Marie Rapp filed an open-market sale of 500 shares at $270 on 2026-06-01 under a 10b5-1 plan.
Limited, mostly sentiment-driven; any reaction likely fades unless follow-on selling or new fundamentals emerge.
Background
SEC Form 4 reports insider transactions; this one is an open-market sale by a director, explicitly noted as under a pre-arranged Rule 10b5-1 plan.
Why it matters
The disclosure can slightly influence short-term sentiment, but it does not introduce new company fundamentals or guidance.
Market relevance
A routine, scheduled insider sale is unlikely to materially change valuation, but may be used as a minor sentiment input.
Market effects
Minimal; this is company-specific insider disclosure with no stated operational/sector-wide trigger.
None indicated.
None indicated.
Alternative perspectives
Because it’s a 10b5-1 plan, the sale may be purely scheduled liquidity rather than bearish information.
Traders should check for clustering of insider transactions (multiple filings) and whether other directors/officers are selling or buying around the same window.
Key entities
- issuerPLEXUS CORP
Subject of the Form 4 insider transaction disclosure.
- directorKaren Marie Rapp
Director who sold 500 shares under a 10b5-1 plan.
